Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age.
de Boer
Sanneke P M
SP
Clinical Epidemiology Unit, Thoraxcenter Cardiology, Erasmus Medical Center, 's Gravendijkwal 230, Rotterdam, the Netherlands.
Westerhout
Cynthia M
CM
Simes
R John
RJ
Granger
Christopher B
CB
Zijlstra
Felix
F
Boersma
Eric
E
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000401:mortality*; D019317:Evidence-Based Medicine; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality* / Q000628:therapy*; D016017:Odds Ratio; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000401:mortality; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000401:mortality*; D013997:Time Factors; D016896:Treatment Outcome